Article info
PDFOriginal research
In vitro fertilisation with preimplantation genetic testing: the need for expanded insurance coverage
- Correspondence to Madison K Kilbride, Medical Ethics and Health Policy, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA; madisonk{at}upenn.edu
Citation
In vitro fertilisation with preimplantation genetic testing: the need for expanded insurance coverage
Publication history
- Received October 2, 2019
- Revised May 29, 2020
- Accepted June 10, 2020
- First published August 19, 2020.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Clinical applications of preimplantation genetic testing
- Preimplantation genetic testing
- Moral reasons to edit the human genome: picking up from the Nuffield report
- Expanding insurance coverage for in vitro fertilisation with preimplantation genetic testing: putting the cart before the horse
- The right not to know and preimplantation genetic diagnosis for Huntington’s disease
- Preimplantation genetic diagnosis and rational choice under risk or uncertainty
- Reproductive carrier screening: responding to the eugenics critique
- Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries
- Birth defects surveillance after assisted reproductive technology in Beijing: a whole of population-based cohort study
- Parental mosaicism detection and preimplantation genetic testing in families with multiple transmissions of de novo mutations